{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:11Z","timestamp":1788383651373,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T00:00:00Z","timestamp":1431561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["III41010"],"award-info":[{"award-number":["III41010"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["ON175069"],"award-info":[{"award-number":["ON175069"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010301","name":"Faculty of Medical Sciences University of Kragujevac","doi-asserted-by":"crossref","award":["\u0408P 06-12"],"award-info":[{"award-number":["\u0408P 06-12"]}],"id":[{"id":"10.13039\/501100010301","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00262-015-1705-5","type":"journal-article","created":{"date-parts":[[2015,5,13]],"date-time":"2015-05-13T16:22:48Z","timestamp":1431534168000},"page":"1011-1019","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cytokine production in patients with papillary thyroid cancer and associated autoimmune Hashimoto thyroiditis"],"prefix":"10.1007","volume":"64","author":[{"given":"Snezana","family":"Zivancevic-Simonovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olgica","family":"Mihaljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Majstorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Milosevic-Djordjevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zorica","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Mijatovic-Teodorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dusan","family":"Mihajlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miodrag","family":"Colic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"1705_CR1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199607113350206","volume":"335","author":"CM Dayan","year":"1996","unstructured":"Dayan CM, Daniels GH (1996) Chronic autoimmune thyroiditis. N Engl J Med 335:99\u2013107","journal-title":"N Engl J Med"},{"key":"1705_CR2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/eje.0.1480383","volume":"148","author":"G Mazziotti","year":"2003","unstructured":"Mazziotti G, Sorvillo F, Naclerio C et al (2003) Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto\u2019s thyroiditis. Eur J Endocrinol 148:383\u2013388","journal-title":"Eur J Endocrinol"},{"issue":"95","key":"1705_CR3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jc.2009-1719","volume":"2010","author":"N Figueroa-Vega","year":"2010","unstructured":"Figueroa-Vega N, Alfonso-P\u00e9rez M, Benedicto I et al (2010) Increased circulating proinflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab 2010(95):953\u2013962","journal-title":"J Clin Endocrinol Metab"},{"key":"1705_CR4","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.4049\/jimmunol.172.10.6427","volume":"172","author":"A Skapenko","year":"2004","unstructured":"Skapenko A, Niedobitek GU, Kalden JR et al (2004) Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 172:6427\u20136434","journal-title":"J Immunol"},{"key":"1705_CR5","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"Marazuela M, Garc\u00eda-L\u00f3pez MA, Figueroa-Vega N et al (2006) Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91:3639\u20133646","journal-title":"J Clin Endocrinol Metab"},{"key":"1705_CR6","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"L Davies","year":"2006","unstructured":"Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973\u20132002. JAMA 295:2164\u20132167","journal-title":"JAMA"},{"key":"1705_CR7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1677\/ERC-07-0085","volume":"14","author":"G Riesco-Eizaguirre","year":"2007","unstructured":"Riesco-Eizaguirre G, Santisteban P (2007) New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy. Endocr Relat Cancer 14:957\u2013977","journal-title":"Endocr Relat Cancer"},{"key":"1705_CR8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF03346494","volume":"32","author":"AG Ozgen","year":"2009","unstructured":"Ozgen AG, Karadeniz M, Erdogan M et al (2009) The (-174) G\/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients. J Endocrinol Invest 32:491\u2013494","journal-title":"J Endocrinol Invest"},{"key":"1705_CR9","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1590\/S1807-59322011000700014","volume":"66","author":"LL Cunha","year":"2011","unstructured":"Cunha LL, Aj Tincani, Assumpcao LV et al (2011) Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancer. Clinics (Sao Paulo) 66:1203\u20131208","journal-title":"Clinics (Sao Paulo)"},{"key":"1705_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00262-014-1619-7","volume":"64","author":"SZ Simonovic","year":"2015","unstructured":"Simonovic SZ, Mihaljevic O, Majstorovic I et al (2015) Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2\/Th9 production before and reduced Th2 cytokine production after radioactive iodine therapy. Cancer Immunol Immunother 64:75\u201382","journal-title":"Cancer Immunol Immunother"},{"key":"1705_CR11","first-page":"6784","volume":"63","author":"G Stassi","year":"2003","unstructured":"Stassi G, Todaro M, Zerilli M et al (2003) Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 63:6784\u20136790","journal-title":"Cancer Res"},{"key":"1705_CR12","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jc.2012-2978","volume":"98","author":"B Jankovic","year":"2013","unstructured":"Jankovic B, Le KT, Hershman JM (2013) Hashimoto\u2019s thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab 98:474\u2013482","journal-title":"J Clin Endocrinol Metab"},{"key":"1705_CR13","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/ERC-14-0229","volume":"21","author":"F Weber","year":"2014","unstructured":"Weber F (2014) Lymphocytes and thyroid cancer: more to it than meets the eye? Endocr Relat Cancer 21:C1\u2013C5","journal-title":"Endocr Relat Cancer"},{"key":"1705_CR14","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/ERC-13-0431","volume":"21","author":"LL Cunha","year":"2014","unstructured":"Cunha LL, Marcello MA, Ward LS (2014) The role of the inflammatory microenvironment in thyroid carcinogenesis. Endocr Relat Cancer 21:R85\u2013R103","journal-title":"Endocr Relat Cancer"},{"key":"1705_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.1998.8.197","volume":"8","author":"K Kashima","year":"1998","unstructured":"Kashima K, Yokoyama S, Noguchi S et al (1998) Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8:197\u2013202","journal-title":"Thyroid"},{"key":"1705_CR16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1067\/msy.2099.101431","volume":"126","author":"B Singh","year":"1999","unstructured":"Singh B, Shaha AR, Trivedi H et al (1999) Coexistent Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: impact of presentation, management and outcome. Surgery 126:1070\u20131077","journal-title":"Surgery"},{"key":"1705_CR17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","volume":"71","author":"EY Kim","year":"2009","unstructured":"Kim EY, Kim WG, Kim WB et al (2009) Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 71:581\u2013586","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1705_CR18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0903","volume":"168","author":"JH Lee","year":"2013","unstructured":"Lee JH, Kim Y, Choi JW et al (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur J Endocrinol 168:343\u2013349","journal-title":"Eur J Endocrinol"},{"key":"1705_CR19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s002680020165","volume":"25","author":"E Kebebew","year":"2001","unstructured":"Kebebew E, Treseler P, Ituarte P, Clark O (2001) Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 25:632\u2013637","journal-title":"World J Surg"},{"key":"1705_CR20","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00405-011-1764-y","volume":"269","author":"LL Cunha","year":"2012","unstructured":"Cunha LL, Ward LS (2012) Concurrent lymphocytic thyroiditis is associated to less aggressive papillary thyroid carcinomas. Eur Arch Otorhinolaryngol 269:699\u2013700","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1705_CR21","first-page":"4591","volume":"26","author":"M Schuetz","year":"2006","unstructured":"Schuetz M, Duan H, Wahl K et al (2006) T Lymphocyte cytokine production patterns in Hashimoto patients with elevated calcitonin levels and their relationship to tumor initiation. Anticancer Res 26:4591\u20134596","journal-title":"Anticancer Res"},{"key":"1705_CR22","first-page":"108","volume-title":"Diagnostic pathology and molecular genetics of the thyroid","author":"YE Nikiforov","year":"2012","unstructured":"Nikiforov YE (2012) Thyroid tumors: classification, staging, and general considerations. In: Nikiforov YE, Biddinger PW, Thompson LDR (eds) Diagnostic pathology and molecular genetics of the thyroid, 2nd edn. Wolters Kluwer\/Lippincott Williams & Wilkins, Philadelphia, pp 108\u2013119","edition":"2"},{"key":"1705_CR23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1189\/jlb.0506297","volume":"80","author":"A Budhu","year":"2006","unstructured":"Budhu A, Wang XW (2006) The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 80:1197\u20131213","journal-title":"J Leukoc Biol"},{"key":"1705_CR24","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/annonc\/mdt175","volume":"24","author":"C Bodelon","year":"2013","unstructured":"Bodelon C, Polley MY, Kemp TJ et al (2013) Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer. Ann Oncol 24:2073\u20132079","journal-title":"Ann Oncol"},{"key":"1705_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2007.00869.x","volume":"70","author":"JI Ellyard","year":"2007","unstructured":"Ellyard JI, Simson L, Parish CR (2007) Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens 70:1\u201311","journal-title":"Tissue Antigens"},{"key":"1705_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20021683","volume":"197","author":"J Mattes","year":"2003","unstructured":"Mattes J, Hulett M, Xie W et al (2003) Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med 197:387\u2013393","journal-title":"J Exp Med"},{"key":"1705_CR27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1634\/theoncologist.2013-0053","volume":"18","author":"M Roy","year":"2013","unstructured":"Roy M, Chen H, Sippel RS (2013) Current understanding and management of medullary thyroid cancer. Oncologist 18:1093\u20131100","journal-title":"Oncologist"},{"key":"1705_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T et al (2004) Interferon-\u03a5: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163\u2013189","journal-title":"J Leukoc Biol"},{"key":"1705_CR29","first-page":"323","volume":"69","author":"GF Prete Del","year":"1987","unstructured":"Del Prete GF, Tiri A, Mariotti S et al (1987) Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto\u2019s thyroiditis. Clin Exp Immunol 69:323\u2013331","journal-title":"Clin Exp Immunol"},{"key":"1705_CR30","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","volume":"17","author":"MR Zaidi","year":"2011","unstructured":"Zaidi MR, Merlino G (2011) The two faces of interferon-\u03a5 in cancer. Clin Cancer Res 17:6118\u20136124","journal-title":"Clin Cancer Res"},{"key":"1705_CR31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","volume":"1182","author":"CH Miller","year":"2009","unstructured":"Miller CH, Maher SG, Young HA (2009) Clinical use of interferon-gamma. Ann N Y Acad Sci 1182:69\u201379","journal-title":"Ann N Y Acad Sci"},{"key":"1705_CR32","doi-asserted-by":"crossref","unstructured":"Hossain MS, Bhimani C, Zhengjia C et al (2011) Profiling counter-regulatory and cytotoxic immune pathways with cellular biomarkers in thyroid cancer patients. [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2\u20136; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 71(8 Suppl):Abstract nr 5525. doi: 10.1158\/1538-7445.AM2011-5525","DOI":"10.1158\/1538-7445.AM2011-5525"},{"key":"1705_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/intimm\/dxu081","volume":"27","author":"S Kang","year":"2015","unstructured":"Kang S, Tanaka T, Kishimoto T (2015) Therapeutic uses of anti-interleukin-6 receptor antibody. Int Immunol 27:21\u201329","journal-title":"Int Immunol"},{"key":"1705_CR34","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","volume":"40","author":"A Kimura","year":"2010","unstructured":"Kimura A, Kishimoto T (2010) IL-6: regulator of Treg\/Th17 balance. Eur J Immunol 40:1830\u20131835","journal-title":"Eur J Immunol"},{"key":"1705_CR35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.intimp.2012.02.003","volume":"12","author":"M Baki","year":"2012","unstructured":"Baki M, Akman FE, Vural P et al (2012) The combination of interleukin-10 -1082 and tumor necrosis factor \u03b1 -308 or interleukin-6 -174 genes polymorphisms suggests an association with susceptibility to Hashimoto\u2019s thyroiditis. Int Immunopharmacol 12:543\u2013546","journal-title":"Int Immunopharmacol"},{"key":"1705_CR36","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.1270357","volume":"127","author":"AP Weetman","year":"1990","unstructured":"Weetman AP, Bright-Thomas R, Freeman M (1990) Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 127:357\u2013361","journal-title":"J Endocrinol"},{"key":"1705_CR37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0960-5428(97)00027-7","volume":"6","author":"RA Ajjan","year":"1996","unstructured":"Ajjan RA, Watson PF, Weetman AP (1996) Cytokines and thyroid function. Adv Neuroimmunol 6:359\u2013386","journal-title":"Adv Neuroimmunol"},{"key":"1705_CR38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/BF03346487","volume":"32","author":"RM Ruggeri","year":"2009","unstructured":"Ruggeri RM, Sciacchitano S, Vitale A et al (2009) Serum hepatocyte growth factor (HGF) is increased in Hashimoto\u2019s thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals. J Endocrinol Invest 32:465\u2013469","journal-title":"J Endocrinol Invest"},{"key":"1705_CR39","first-page":"112","volume":"61","author":"L Sieminska","year":"2010","unstructured":"Sieminska L, Wojciechowska C, Kos-Kudla B et al (2010) Serum concentrations of leptin, adiponectin, and interleukin-6 in postmenopausal women with Hashimoto\u2019s thyroiditis. Endokrynol Pol 61:112\u2013116","journal-title":"Endokrynol Pol"},{"key":"1705_CR40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3181\/00379727-195-43129D","volume":"195","author":"PB Sehgal","year":"1990","unstructured":"Sehgal PB (1990) Interleukin 6 in infection and cancer. Proc Soc Exp Biol Med 195:183\u2013191","journal-title":"Proc Soc Exp Biol Med"},{"key":"1705_CR41","doi-asserted-by":"crossref","unstructured":"Kura Y, De Velasco MA, Kobayashi Y, et al (2013) Interleukin-6 (IL-6) as a therapeutic target in prostate cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6\u201310; Washington, DC. Philadelphia (PA): AACR; Cancer Res 73(8 Suppl):Abstract nr 1226. doi: 10.1158\/1538-7445.AM2013-1226","DOI":"10.1158\/1538-7445.AM2013-1226"},{"key":"1705_CR42","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/0008-5472.CAN-13-1558-T","volume":"73","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Yan W, Collins MA et al (2013) Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res 73:6359\u20136374","journal-title":"Cancer Res"},{"key":"1705_CR43","first-page":"3251","volume":"32","author":"H Ujiie","year":"2012","unstructured":"Ujiie H, Tomida M, Akiyama H et al (2012) Serum hepatocyte growth factor and interleukin-6 are effective prognostic markers for non-small cell lung cancer. Anticancer Res 32:3251\u20133258","journal-title":"Anticancer Res"},{"key":"1705_CR44","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12022-011-9164-9","volume":"22","author":"BY Huang","year":"2011","unstructured":"Huang BY, Hseuh C, Chao TC et al (2011) Well-differentiated thyroid carcinoma with concomitant Hashimoto\u2019s thyroiditis present with less aggressive clinical stage and low recurrence. Endocr Pathol 22:144\u2013149","journal-title":"Endocr Pathol"},{"key":"1705_CR45","first-page":"129","volume":"4","author":"TH Ng","year":"2013","unstructured":"Ng TH, Britton GJ, Hill EV et al (2013) Regulation of adaptive immunity; the role of interleukin-10. Front Immunol 4:129\u2013140","journal-title":"Front Immunol"},{"key":"1705_CR46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1242\/dmm.015099","volume":"7","author":"DE Smilek","year":"2014","unstructured":"Smilek DE, Ehlers MR, Nepom GT (2014) Restoring the balance: immunotherapeutic combinations for autoimmune disease. Dis Model Mech 7:503\u2013513","journal-title":"Dis Model Mech"},{"key":"1705_CR47","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.4049\/jimmunol.150.11.4754","volume":"150","author":"R Waal-Malefyt de","year":"1993","unstructured":"de Waal-Malefyt R, Yssel H, de Vries JE (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754\u20134765","journal-title":"J Immunol"},{"key":"1705_CR48","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/IAI.00047-11","volume":"79","author":"JC Cyktor","year":"2011","unstructured":"Cyktor JC, Turner J (2011) Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect Immunol 79:2964\u20132973","journal-title":"Infect Immunol"},{"key":"1705_CR49","first-page":"1119","volume":"32","author":"AL Franks","year":"2012","unstructured":"Franks AL, Slansky JE (2012) Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 32:1119\u20131136","journal-title":"Anticancer Res"},{"key":"1705_CR50","doi-asserted-by":"crossref","unstructured":"Luheshi N, Davies GC, Poon E et al (2013) Th1 and Th2 cytokines determine how CD40 activation changes human macrophage function in vitro. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6\u201310; Washington, DC. Philadelphia (PA): AACR; Cancer Res 73(8 Suppl):Abstract nr 1542. doi: 10.1158\/1538-7445.AM2013-1542","DOI":"10.1158\/1538-7445.AM2013-1542"},{"key":"1705_CR51","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00262-013-1434-6","volume":"62","author":"JC Becker","year":"2013","unstructured":"Becker JC, Andersen MH, Schrama D et al (2013) Immune-suppressive properties of the tumor microenvironment. Cancer Immunol Immunother 62:1137\u20131148","journal-title":"Cancer Immunol Immunother"},{"key":"1705_CR52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/0008-5472.CAN-13-2322","volume":"74","author":"T Atsumi","year":"2014","unstructured":"Atsumi T, Singh R, Sabharwal L et al (2014) Inflammation amplifier, a new paradigm in cancer biology. Cancer Res 74:8\u201314","journal-title":"Cancer Res"},{"key":"1705_CR53","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/ERC-14-0096","volume":"22","author":"JI Murray","year":"2014","unstructured":"Murray JI, West NR, Murphy LC et al (2014) Intratumoral inflammation and endocrine resistance in breast cancer. Endocr Relat Cancer 22:R51\u2013R67","journal-title":"Endocr Relat Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1705-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-015-1705-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-015-1705-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T13:31:06Z","timestamp":1691674266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-015-1705-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s00262-015-1705-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}